serena williams using glp 1 JOINS RO AS GLP-1 CELEBRITY AMBASSADOR Serena Williams discusses GLP-1 use

This recommendation is based on the lack of human safety data and concerns about potential risks to a developing fetus

Mounjaro ICD-10 Coding Guide for UK Clinicians Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, offering significant glycaemic control and weight reduction

Their clinical advantage in managing type 2 diabetes and obesity has positioned them strongly in treatment guidelines

And here is the important part: if you miss two or more consecutive doses, you may need to restart the full titration schedule from 0.25 mg to avoid severe gastrointestinal side effects